Concepedia

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

Jean‐Yves Blay, Antoîne Italiano, Isabelle Ray‐Coquard, Axel Le Cesne, Florence Duffaud, María Rios, Olivier Collard, François Bertucci, Emmanuelle Bompas, Nicolás Isambert,

BMC Cancer · 2013 · 75 citations · 27 references

DOIFull text

Open access

References

27

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis et al. · Journal of Clinical Oncology · 1999 · 565 citations

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

George D. Demetri, Sant P. Chawla, Margaret von Mehren et al. · Journal of Clinical Oncology · 2009 · 524 citations · Full text

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, Jean‐Yves Blay · Annals of Oncology · 2010 · 479 citations · Full text

, , +10

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Axel Le Cesne, Jean‐Yves Blay, Ian Judson et al. · Journal of Clinical Oncology · 2005 · 418 citations

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

Ian Judson, John Radford, Martin Harris et al. · European Journal of Cancer · 2001 · 382 citations

, , +8